6 July 2026 CEO blog – 6 July 2026 Chris Molloy on scale-up policy, improving treatments pipeline, LSSP, GMM regulation, LLSW, MDUK's Pedal Paddle Peak and Dr Sally Ann Forsyth OBE Blog
6 July 2026 The unmissable event that propels life sciences forward Key takeaways as another BIA Summer Party 2026 delivers for the life sciences sector Blog
6 July 2026 The new opportunity for UK biotech companies to attract global talent The Global Talent visa route has been made easier for research-intensive businesses to attract international researchers and specialists Blog
6 July 2026 Myricx Bio to be acquired by Novartis to advance next-generation ADC payloads for oncology Myricx Bio reached agreement to be acquired by Novartis for up to $1.5 billion. Member news
6 July 2026 Oxford Medical Products appoints Craig Marshall as Independent Non-Executive Director Craig Marshall, $1.5B OrganOx exit CEO, joins Oxford Medical Products board Member news
3 July 2026 Life sciences industry calls for policy continuity to help companies scale at BIA roundtable with Dr Zubir Ahmed MP The UK’s innovative life sciences sector has called on Government to deliver policy continuity, unlock scale-up investment and improve patient access to new medicines. Press release
